The IDO inhibitors ethyl pyruvate and amidoxime slightly suppress the growth of the Ehrlich tumor in mice and potentiates the therapeutic effect of cyclophosphamide [97]. The gene discussed is IDO1; the disease is Ehrlich tumor carcinoma.